AUBRIE JONES: Open Payments
NPI 1730819129 · SEAL BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,592 in 149 payments from 24 companies in 2025. Trend: 2023 $1,344 · 2024 $3,841 · 2025 $3,592
Food & beverage: $3,324Education: $268
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $643 |
| UCB, Inc. | 13 | $528 |
| Janssen Biotech, Inc. | 14 | $353 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $269 |
| GENZYME CORPORATION | 7 | $257 |
| Regeneron Healthcare Solutions, Inc. | 7 | $197 |
| MIMEDX Group, Inc. | 13 | $178 |
| PFIZER INC. | 10 | $171 |
| LEO Pharma Inc. | 8 | $154 |
| Incyte Corporation | 6 | $136 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, CIBINQO, OPZELURA, ADBRY.
Industry payments across CA — which companies pay providers there.
